Therapeutic Drug Monitoring of Tocilizumab in Rheumatoid Arthritis

NCT03781310 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

80

Enrollment

OTHER_GOV

Sponsor class

Conditions

Rheumatoid Arthritis
Tocilizumab

Interventions

DRUG: Tocilizumab

Sponsor

Tel-Aviv Sourasky Medical Center

Collaborators

[object Object]